Focal One HIFU (High‑Intensity Focused Ultrasound) is an advanced, minimally invasive treatment
used primarily for prostate diseases, including localized prostate cancer. The technology uses focused ultrasound energy to precisely target and destroy abnormal prostate tissue without the need for traditional surgery. Focal One represents one of the latest developments in precision medicine, allowing doctors to treat only the affected area of the prostate while preserving healthy surrounding tissue. This approach helps reduce many of the side effects commonly associated with traditional prostate surgery or radiation therapy.
Focal One is a robotic‑assisted High‑Intensity Focused Ultrasound (HIFU) system designed specifically for prostate treatment. It combines advanced imaging, ultrasound energy, and precise treatment planning to destroy targeted prostate tissue.
During the procedure, focused ultrasound waves generate heat that destroys cancerous or abnormal cells inside the prostate. The treatment is performed without surgical incisions, making it a minimally invasive option
for suitable patients.
Focal One HIFU is primarily used for prostate-related conditions such as:
The Focal One treatment process typically includes several steps:
Focal One treatment may be considered for patients with localized prostate cancer who wish to avoid more aggressive treatments such as radical prostate surgery.
A detailed evaluation by a urologist or prostate cancer specialist is required to determine whether Focal One HIFU is the most appropriate treatment option for the patient’s condition.
Focal One offers several potential advantages compared to conventional
prostate surgery or radiation therapy:
Because Focal One HIFU is minimally invasive, many patients experience a
relatively quick recovery. Most patients are able to return home within a short period after the procedure.
Temporary urinary symptoms may occur during the healing process, but many patients resume normal activities within a short time under medical guidance. Follow‑up monitoring and PSA testing are typically recommended to evaluate treatment success.
Focal One HIFU represents an important advancement in prostate cancer treatment. By combining
high‑precision imaging with focused ultrasound energy, this technology allows doctors to treat prostate disease in a targeted and minimally invasive way.
For suitable patients, Focal One offers an effective treatment option that balances cancer control with preservation of quality of life.
MediAssist Penang is a doctor-led international cancer referral platform connecting patients to top hospitals and leading oncology specialists worldwide. We specialize in advanced and non-invasive cancer treatments, offering hope for Stage 3, Stage 4, and complex cancer cases.
2194,jalan Bukit minyak, kawasan perniagaan asas murni, Bukit mertajam, penang 14000